These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 9166485
1. Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy. Henry DH, Brooks BJ, Case DC, Fishkin E, Jacobson R, Keller AM, Kugler J, Moore J, Silver RT, Storniolo AM, Abels RI, Gordon DS, Nelson R, Larholt K, Bryant E, Rudnick S. Cancer J Sci Am; 1995; 1(4):252-60. PubMed ID: 9166485 [Abstract] [Full Text] [Related]
2. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies. Henry DH, Abels RI. Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722 [Abstract] [Full Text] [Related]
3. [Recombinant human erythropoietin in the treatment of anemic patients undergoing chemotherapy for cancer]. Bösze P, Mayer A, Thurzó L, Kiss A, Rák K, Stumpf J. Orv Hetil; 1995 Nov 19; 136(47):2567-72. PubMed ID: 8532322 [Abstract] [Full Text] [Related]
4. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results. Phair JP, Abels RI, McNeill MV, Sullivan DJ. Arch Intern Med; 1993 Dec 13; 153(23):2669-75. PubMed ID: 8250662 [Abstract] [Full Text] [Related]
5. [Recombinant human erythropoietin in anemia associated with pediatric cancer: study of the identification of predictors of response]. León Molinari P, Jiménez Monteagudo M, Barona Zamora P, Riol Diego M, Castro Paz L, Sierrasesúmaga Ariznavarreta L. An Esp Pediatr; 1998 Jul 13; 49(1):17-22. PubMed ID: 9718761 [Abstract] [Full Text] [Related]
6. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy. Malik IA, Khan ZK, Hakimali A, Sabih M, Rehman G. J Pak Med Assoc; 1998 May 13; 48(5):127-31. PubMed ID: 9813972 [Abstract] [Full Text] [Related]
9. Recombinant human erythropoietin for the treatment of anemia in patients with advanced cancer. Henry DH. Semin Hematol; 1993 Oct 13; 30(4 Suppl 6):12-6. PubMed ID: 8153671 [Abstract] [Full Text] [Related]
11. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials. Henry DH, Beall GN, Benson CA, Carey J, Cone LA, Eron LJ, Fiala M, Fischl MA, Gabin SJ, Gottlieb MS. Ann Intern Med; 1992 Nov 01; 117(9):739-48. PubMed ID: 1416576 [Abstract] [Full Text] [Related]
12. Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy. Shasha D, George MJ, Harrison LB. Cancer; 2003 Sep 01; 98(5):1072-9. PubMed ID: 12942577 [Abstract] [Full Text] [Related]
13. Erythropoietin reduces anemia and transfusions after chemotherapy with paclitaxel and carboplatin. Dunphy FR, Dunleavy TL, Harrison BR, Boyd JH, Varvares MA, Dunphy CH, Rodriguez JJ, McDonough EM, Minster JR, McGrady MD. Cancer; 1997 Apr 15; 79(8):1623-8. PubMed ID: 9118049 [Abstract] [Full Text] [Related]
16. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Shannon KM, Keith JF, Mentzer WC, Ehrenkranz RA, Brown MS, Widness JA, Gleason CA, Bifano EM, Millard DD, Davis CB. Pediatrics; 1995 Jan 15; 95(1):1-8. PubMed ID: 7770284 [Abstract] [Full Text] [Related]